Alterity Therapeutics (PRNAD) Other Non-Current Liabilities (2009 - 2025)

Alterity Therapeutics (PRNAD) has reported Other Non-Current Liabilities for 16 consecutive years, with $617156.7 the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities rose 60.79% year-over-year to $617156.7; the TTM figure through Dec 2025 stood at $617156.7 (up 60.79% YoY), while the FY2025 annual figure was $560960.6, up 60.39% from the prior year.
• Other Non-Current Liabilities came in at $617156.7 for Q4 2025 at Alterity Therapeutics, up from $560960.6 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $617156.7 in Q4 2025, with the low at $5307.0 in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $379120.2, with a median of $436594.4 recorded in 2021.
• Across the five-year window, Other Non-Current Liabilities jumped 72636.73% in 2021 and slumped 98.45% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $446642.3 in 2021, then grew by 2.9% to $459591.4 in 2022, then slipped by 7.19% to $426546.5 in 2023, then retreated by 10.01% to $383839.2 in 2024, then surged by 60.79% to $617156.7 in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $617156.7, $560960.6, and $383839.2 for Q4 2025, Q2 2025, and Q4 2024 respectively.